Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Jan 27, 2010 kolinski stuart Officer Option Execute 4,359 8.50
Jan 27, 2010 roberts william Officer Automatic Sell 4,381 26.57
Nov 29, 2012 aberman michael s Officer Automatic Sell 4,430 182.20
May 18, 2010 brown michael s Director Disposition (Non Open Market) 4,476 28.40
May 27, 2010 gilman alfred g Director Disposition (Non Open Market) 4,553 27.92
Feb 14, 2012 mccorkle douglas s Officer Sell 4,562 109.01 - 110.50
Feb 18, 2011 goldberg murray a Officer Automatic Sell 4,569 36.87 - 37.29
Jan 26, 2011 goldstein joseph l Director Automatic Sell 4,599 34.35
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
Dec 14, 2012 goldberg murray a Officer Automatic Sell 4,607 179.13
Dec 14, 2011 goldberg murray a Officer Automatic Sell 4,622 51.18
Dec 18, 2012 mccorkle douglas s Officer Option Execute 4,625 21.25
Oct 29, 2009 goldberg murray a Officer Option Execute 4,643 8.77
Mar 13, 2013 schleifer leonard s Officer Automatic Sell 4,662 175.01
Dec 16, 2010 goldstein joseph l Director Automatic Sell 4,719 31.80
Aug 4, 2011 van plew daniel p Officer Option Execute 4,784 20.90
Jan 18, 2011 brown michael s Director Automatic Sell 4,845 34.88
Apr 4, 2011 vagelos p roy Officer Disposition (Non Open Market) 4,954 n/a
Sep 6, 2011 aberman michael s Officer Automatic Sell 4,957 65.76
Oct 1, 2008 mccorkle douglas s Officer Automatic Sell 4,957 21.22 - 21.60
Showing 121-140 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)